首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   319篇
  免费   43篇
林业   39篇
农学   3篇
基础科学   1篇
  21篇
综合类   37篇
农作物   6篇
水产渔业   20篇
畜牧兽医   203篇
园艺   4篇
植物保护   28篇
  2023年   4篇
  2021年   6篇
  2020年   7篇
  2019年   9篇
  2018年   19篇
  2017年   10篇
  2016年   15篇
  2015年   9篇
  2014年   16篇
  2013年   21篇
  2012年   11篇
  2011年   22篇
  2010年   6篇
  2009年   12篇
  2008年   10篇
  2007年   8篇
  2006年   10篇
  2005年   8篇
  2004年   6篇
  2003年   11篇
  2002年   9篇
  2001年   7篇
  2000年   9篇
  1999年   2篇
  1998年   8篇
  1997年   12篇
  1996年   8篇
  1995年   3篇
  1994年   6篇
  1993年   6篇
  1992年   6篇
  1990年   6篇
  1989年   4篇
  1988年   9篇
  1987年   3篇
  1986年   3篇
  1985年   2篇
  1984年   2篇
  1983年   3篇
  1982年   3篇
  1977年   5篇
  1976年   3篇
  1927年   1篇
  1926年   3篇
  1924年   1篇
  1916年   1篇
  1914年   1篇
  1909年   2篇
  1900年   1篇
  1883年   1篇
排序方式: 共有362条查询结果,搜索用时 31 毫秒
101.
102.
103.
104.
The purpose of this study was to evaluate short-term adverse effects and determine a safe dosage for vinorelbine (Navelbine)--a new semisynthetic vinca alkaloid--in dogs with malignant tumors. Nineteen dogs were treated with vinorelbine as a 5-minute IV infusion every 7 days at starting dosages ranging from 10 to 20 mg/m2. The median number of treatments per dog was 7 (range, 1-11). The maximum tolerated dosage varied between 15 and 18 mg/m2, and a starting dosage of 15 mg/m2 is recommended. Neutropenia was the dose-limiting toxicity. Although efficacy was a secondary endpoint of this dosage-finding study, 2 dogs with metastatic bronchoalveolar carcinoma experienced a partial response for an overall response rate of 12.5% in 16 dogs with gross measurable disease. Three dogs with microscopic disease were treated (incompletely excised bronchoalveolar carcinoma or lymph node metastatic disease). Two died of pulmonary metastatic disease 113 and 196 days posttreatment, and 1 is still alive after at least 730 days. The well-tolerated toxicity profile and clinical activity observed in dogs with bronchoalveolar carcinoma warrants further investigation.  相似文献   
105.
106.
Yellow tang, Zebrasoma flavescens, are one of the most heavily traded marine aquarium fish species, with nearly 400,000 individuals collected annually from Hawaii's reefs. Despite recent success culturing this species, significant challenges in the rearing processes remain to be overcome before commercialization is feasible. This study compared two feeding regimens, an original diet treatment, which was initially used to successfully culture yellow tang, and a revised diet, which differed in the timing of the introduction of feed items and weaning periods. Both diet regimens consisted of Parvocalanus crassirostris nauplii, enriched Brachionus rotundiformis rotifers, and Artemia nauplii, followed by a transition to dry and frozen feed items. The revised feeding regimen aimed to considerably reduce the amount of copepods and rotifers needed in the rearing process. Eggs were stocked at 40/L into replicate (n = 3) 200‐L tanks for the feeding regimen trial. A follow‐up rearing study, in which eggs were stocked at 19/L in a single 1000‐L tank, tested the revised feeding method at pilot scale. Fish reared on the revised feeding regimen were observed to grow faster in body length and body depth after 2 wk in culture and transitioned more quickly to juveniles as 41% had completed their transition to juvenile coloration by 70 d after hatch. None of the fish reared under the original feeding regimen attained full juvenile coloration during the study period. Survival was not significantly different between treatments and was 0.13% ± 0.13 and 0.29% ± 0.17 in the original and revised feeding regimens, respectively. In the pilot‐scale study, growth was comparable to that of both treatments in the 200‐L scale trial, but survival was much better at 1.9%. This study successfully shortened the copepod and rotifer feeding periods for yellow tang, while not jeopardizing growth or survival. This outcome enhances the commercialization potential for this and likely other Acanthuridae species.  相似文献   
107.
The cat flea, Ctenocephalides felis, is the most important ectoparasite of cats and dogs worldwide as a cause of irritation and health problems. Most products to control these pests in the household environment rely upon a combination of neurotoxic insecticides and insect growth regulators to inhibit development of flea eggs and larvae into adults. However, some of these are affected by problems of insecticide resistance as well as public concerns about their potential for toxicity in domestic use. Heavy synthetic oils, like the siloxane dimeticone, are currently widely used to treat human ectoparasite infestations, acting by a physical mode of action, and have been used in a variety of presentations for killing all life stages of fleas. We have investigated the activity of low concentrations of high molecular weight dimeticone in a volatile silicone base for ability to immobilise flea life stages without asphyxiating them. We found that cat flea adults and larvae were immobilised by a surface film of dimeticone that inhibited movement of cuticular joints, apparently forming an effective sticky trap. When cocoons were treated the fleas continued to develop within the pupae but failed to emerge. An aerosol spray incorporating 0.4% concentration of dimeticone, for use as a residual household treatment, showed no significant difference in knock down capability compared with that of a widely used pyriproxifen/permethrin spray in a repeat challenge test, with effects persisting to inhibit adult flea emergence in the test arena area for more than 3 weeks after application.  相似文献   
108.

Background

Canine cutaneous T‐cell lymphoma (CTCL) is an uncommon disease for which efficacious therapies are lacking. The novel anticancer nucleotide prodrug VDC‐1101 (formerly known as GS‐9219) has shown efficacy in dogs with multicentric lymphoma. One of the observed adverse effects with this drug was a skin change characterized by hair loss, erythema, and pruritus, implying delivery of VDC‐1101 to the skin.

Hypothesis/Objectives

The primary study objective was to identify the objective response rate (ORR) to VDC‐1101 in canine CTCL; secondary objectives included characterization of progression‐free survival (PFS) and adverse events (AEs).

Animals

Twelve dogs with chemotherapy‐naïve or relapsed, histologically and immunohistochemically confirmed CTCL.

Methods

Dogs received VDC‐1101 as a 30‐minute IV infusion once every 21 days. Prednisone (1 mg/kg PO q48h) was administered concurrently.

Results

In 11 evaluable patients, responses included 1 complete response (CR), 4 partial responses (PR), 2 stable disease (SD), and 4 progressive disease for an ORR of 45% and biologic response rate (CR/PR/SD) of 64%. The median PFS was 37.5 days (26 to >399 days), which includes 1 durable and ongoing CR (>1 year). Gastrointestinal and hematologic AEs were mild; no dogs developed grade 3 or 4 AEs. Three dogs developed dermatopathies and 1 of these dogs was removed from the study as a result of this AE.

Conclusions and Clinical Importance

VDC‐1101 has activity against canine CTCL and could provide another treatment option in a disease process with a poor prognosis.  相似文献   
109.
A 3‐year‐old Marwari mare was presented for evaluation of an irregular, reddish mass protruding from behind the right third eyelid. The mass appeared to arise at the ventral limbal area, involved the perilimbal bulbar conjunctiva and widely extended into corneal tissue. No other ocular or systemic abnormalities were detected at the time of presentation. The mass was surgically removed by lamellar keratectomy, with defocused CO2 laser used as adjunctive therapy to treat the surgical exposed area and its surroundings. Histopathologic evaluation showed sheets of densely packed, well‐differentiated neoplastic mast cells separated by fibrovascular connective tissue. Nuclear staining for Ki‐67 was performed, and an average of 370 cells were positive per 1000 counted cells. Two months postoperatively, the surgical site was filled with flat fibrovascular and pigmented tissue, while the surrounding cornea was transparent with no superficial vascularization around the fibrotic scar. Thirty‐two months after treatment, no recurrence of the neoplasia was reported.  相似文献   
110.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号